Center for Nanobiology and Predictive Toxicology
纳米生物学和预测毒理学中心
基本信息
- 批准号:8464703
- 负责人:
- 金额:$ 105.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-24 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Center for Nanobiology and Predictive Toxicology has assembled a multidisciplinary team with expertise in nanomaterial science, toxicology, cell biology, high throughput screening, biostatistics, mathematics and computer science with the overall goal of gaining fundamental understanding of how the physical and Chemical properties of carefully selected ENM libraries relate to interactions with cells and cellular structures, including how these bio-physicochemical interactions at the nano-bio interface may lead to pulmonary toxicity. This goal will be executed through the acquisition, synthesis and characterization of compositional and combinatorial ENM libraries that focus on the major physicochemical properties of nominated metal, metal oxide and silica nanoparticles {Scientific Core), hypothesized to play a role in pulmonary toxicity through the generation of oxidative stress, inflammation, signal pathway activation and membrane lysis. These efforts will be assisted by in silico modeling that use heatmaps, mathematical models and machine learning to perform hazard ranking and risk prediction. The major objectives of the Center are: (i) To establish an overarching predictive toxicological paradigm, which is defined as the assessment of in vivo toxic potential of ENM based on in vitro and in silico methods (integrated center effort); (ii) To establish rapid throughput cellular screening and conduct imaging to identify compositional and combinatorial ENM properties that lead to bioavailability and engagement of the injury pathways discussed above (Project 1); (iii) To establish through the performance of instillation and inhalation exposures in the rodent lung how the structure-property relationships linking ENM to in vitro injury mechanisms may be predictive of pulmonary inflammation, fibrosis and cytotoxicity in a dose-dependent fashion (Project 2); (iv) To develop in silico toxicity models that utilize multivariate analysis of the rapid throughput screening and cellular imaging data to show the relationships that can be used to develop "nano-QSARs" for probabilistic risk ranking (Project 3).
描述(由申请人提供):纳米生物学和预测毒理学中心已经组装了一个具有纳米材料科学,毒理学,细胞生物学,高吞吐量筛查,生物统计学,数学和计算机科学的多学科团队,并与对精心选择的细胞相互作用的整体了解,并将其与化学群体相互作用的整体理解与构建方式相互作用,以使这些型号的整体了解与这些细胞相互作用,并纳米生物生物界面处的生物化学相互作用可能导致肺毒性。该目标将通过对构图和组合ENM库的获取,合成和表征来执行,该库的重点是指定金属,金属氧化物和硅胶粒子的主要物理化学特性(Scientific Core),假设通过氧化应激,氧化压力,信号pation,Signal,Membrance Active和Membrance Active and of肺毒性起作用,从而在肺部毒性中起作用。这些努力将通过使用热图,数学模型和机器学习来执行危险排名和风险预测的计算机建模来协助这些努力。该中心的主要目标是:(i)建立一个总体预测毒理范式,该范式定义为基于体外和计算机方法(综合中心努力)的ENM体内毒性潜力的评估; (ii)建立快速的吞吐量细胞筛选并进行成像,以识别导致上述损伤途径的生物利用度和参与度的组成和组合特性(项目1); (iii)通过在啮齿动物肺中进行灌注和吸入暴露的性能来建立结构 - 培养基关系如何将ENM与体外损伤机制联系起来可能预测肺部炎症,纤维化和细胞毒性以剂量依赖的方式(项目2); (iv)在使用快速吞吐量筛选和细胞成像数据的多元分析的硅毒性模型中发展,以显示可用于开发概率风险排名的“纳米QSAR”的关系(项目3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Andre Elias Nel的其他基金
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
- 批准号:1018753310187533
- 财政年份:2020
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
- 批准号:1005818910058189
- 财政年份:2020
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
- 批准号:1041716110417161
- 财政年份:2020
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
- 批准号:1065481610654816
- 财政年份:2020
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
- 批准号:91867359186735
- 财政年份:2016
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
- 批准号:93413219341321
- 财政年份:2016
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
- 批准号:97697289769728
- 财政年份:2016
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Center for Nanobiology and Predictive Toxicology
纳米生物学和预测毒理学中心
- 批准号:83939658393965
- 财政年份:2010
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs
Nanovalve平台:靶向、可控、释放抗癌药物
- 批准号:82068048206804
- 财政年份:2010
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
相似国自然基金
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
脉络膜黑色素瘤循环血内肿瘤细胞的捕获、扩增、生物学特征分析与外泌体载药模型构建的研究
- 批准号:82303540
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多时序多模态MR特征和人工智能技术构建骨肉瘤预后的早期预测模型及其生物学可解释性研究
- 批准号:82373108
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肝癌核磁共振影像组学特征的肿瘤生物学意义及其机制研究
- 批准号:82372037
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
土壤缓步动物的形态学和分子生物学鉴定及其分布特征
- 批准号:42377288
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Investigating the role of GAPDHS in melanoma metabolism and metastasis
研究 GAPDHS 在黑色素瘤代谢和转移中的作用
- 批准号:1064366910643669
- 财政年份:2023
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.
解码肿瘤代谢和免疫相互作用导致非裔美国膀胱癌患者的种族差异。
- 批准号:1071878710718787
- 财政年份:2023
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Developing novel LOX inhibitors to target chemotherapy resistant TNBC
开发新型 LOX 抑制剂以靶向化疗耐药的 TNBC
- 批准号:1069681010696810
- 财政年份:2023
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia
改善患有急性淋巴细胞白血病的拉丁裔儿童和青少年的结果差异
- 批准号:1047269610472696
- 财政年份:2021
- 资助金额:$ 105.49万$ 105.49万
- 项目类别:
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia
改善患有急性淋巴细胞白血病的拉丁裔儿童和青少年的结果差异
- 批准号:1028949310289493
- 财政年份:2021
- 资助金额:$ 105.49万$ 105.49万
- 项目类别: